Back to Authors

Heffernan, Timothy P.

https://orcid.org/0000-0002-3166-8922

A5065349307 | I1343551460

Mayo Clinic

The University of Texas MD Anderson Cancer Center

Citations 1

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

Science Translational Medicine | March 13, 2019 | Volume: 11 | Issue: 483 | Pages: No page available

10.1126/scitranslmed.aaq1238 | PMID 30867319

Suppression of ZEB1 through miR-200 expression or HDAC inhibition with mocetinostat sensitizes resistant KRAS mutant lung cancers to MEK inhibition.